COMBINATION OF SORAFENIB AND 5-AZACYTIDINE HAS SIGNIFICANT ACTIVITY IN PATIENTS WITH RELAPSED/REFRACTORY OR UNTREATED ACUTE MYELOID LEUKEMIA AND FLT3-ITD MUTATION

被引:0
|
作者
Ravandi, Farhad [1 ]
Alattar, Mona Lisa [1 ]
Levis, Mark [1 ]
Garcia-Manero, Guillermo [1 ]
Richie, Mary A. [1 ]
Daver, Naval [1 ]
Faderl, Stefan [1 ]
Borthakur, Gautam [1 ]
Burger, Jan [1 ]
Kadia, Tapan [1 ]
Grunwald, Michael [1 ]
Dellasala, Sara [1 ]
Cortes, Jorge [1 ]
Kantarjian, Hagop [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
45
引用
收藏
页码:S19 / S20
页数:2
相关论文
共 50 条
  • [21] Ultrasensitive quantitation of FLT3-ITD mutation in patients with acute myeloid leukemia using ddPCR
    Kojabad, Amir Asri
    Chegeni, Rouzbeh
    Rostami, Shaharbano
    Zaker, Farhad
    Safa, Majid
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (07) : 6097 - 6105
  • [22] An Iridociliochoroidal Myeloid Sarcoma Associated With Relapsed Acute Myeloid Leukemia With FLT3-ITD Mutation, Treated With Gilteritinib, an FLT3 Inhibitor
    Kim, Ryan S.
    Yaghy, Antonio
    Wilde, Lindsay R.
    Shields, Carol L.
    JAMA OPHTHALMOLOGY, 2020, 138 (04) : 418 - 419
  • [23] Influence of FLT3-ITD Mutation and Length on the Prognosis in Acute Myeloid Leukemia
    Jiang, Xuejie
    Chen, Fang
    Yin, Changxin
    Jiang, Ling
    Yu, Guo-Pan
    Xu, Dan
    Sun, Jing
    Liu, Xiaoli
    Liu, Qifa
    BLOOD, 2017, 130
  • [24] The potential of triplet combination therapies for patients with FLT3-ITD -mutated acute myeloid leukemia
    Bruzzese, Antonella
    Vigna, Ernesto
    Martino, Enrica Antonia
    Labanca, Caterina
    Mendicino, Francesco
    Lucia, Eugenio
    Olivito, Virginia
    Stanzione, Gaia
    Zimbo, Annamaria
    Lugli, Elisabetta
    Neri, Antonino
    Morabito, Fortunato
    Gentile, Massimo
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (06) : 241 - 253
  • [25] Ultrasensitive quantitation of FLT3-ITD mutation in patients with acute myeloid leukemia using ddPCR
    Amir Asri kojabad
    Rouzbeh Chegeni
    Shaharbano Rostami
    Farhad Zaker
    Majid Safa
    Molecular Biology Reports, 2023, 50 : 6097 - 6105
  • [26] Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3-ITD: A multicenter phase 2 study
    Yu, Sijian
    Zhang, Yu
    Yu, Guopan
    Wang, Yu
    Shao, Ruoyang
    Du, Xin
    Xu, Na
    Lin, Dongjun
    Zhao, Weihua
    Zhang, Xiong
    Xiao, Jie
    Sun, Zhiqiang
    Deng, Lan
    Liang, Xinquan
    Zhang, Hongyu
    Guo, Ziwen
    Dai, Min
    Shi, Pengcheng
    Huang, Fen
    Fan, Zhiping
    Liu, Qiong
    Lin, Ren
    Jiang, Xuejie
    Xuan, Li
    Liu, Qifa
    Jin, Hua
    JOURNAL OF INTERNAL MEDICINE, 2024, 295 (02) : 216 - 228
  • [27] Trial Test of Sorafenib Alone or in Combination with Chemotherapy for Treating Refractory and Relapsed Acute Myeloid Leukemia with FLT3 Mutation
    Miao, Miao
    Wu Depei
    Sun, Aining
    Xu, Ting
    Jin, Song
    Yan, Lingzhi
    Bao, Haiyan
    BLOOD, 2014, 124 (21)
  • [28] 5-Azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy
    Ivanoff, Sarah
    Gruson, Berengere
    Chantepie, Sylvain P.
    Lemasle, Emilie
    Merlusca, Lavinia
    Harrivel, Veronique
    Charbonnier, Amandine
    Votte, Patrick
    Royer, Bruno
    Marolleau, Jean-Pierre
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (07) : 601 - 605
  • [29] Combination of Omacetaxine Mepesuccinate (homoharringtonine) and Sorafenib As an Effective Regimen for Acute Myeloid Leukemia (AML) Carrying FLT3-ITD
    Leung, Garret M. K.
    Zhang, Chunxiao
    To, Alan W. L.
    Lam, Stephen S. Y.
    Kwong, Yok Lam
    Leung, Anskar
    BLOOD, 2017, 130
  • [30] Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib in Acute Myeloid Leukemia with FLT3-ITD Mutation or Monosomy 5, 7, or Complex Cytogenetics
    Abu Zaid, Mohammad
    Boswell, H. Scott
    Cripe, Larry D.
    Liu, Yan
    Weisenbach, Jill
    Sayar, Hamid
    BLOOD, 2014, 124 (21)